Which Is the Better High Dividend ETF, iShares' HDV or Fidelity's FDVV?

HDV and FDVV both yield 2.80% trailing-12-month, but HDV is cheaper (0.08% expense ratio vs 0.15%) and shows lower risk (5-year max drawdown -15.4% vs -20.2%, beta 0.53 vs 0.86). Over 5 years, a $1,000 investment grew to $1,673 for HDV versus $1,883 for FDVV, reflecting FDVV’s more tech-heavy (31%) portfolio. Key tradeoff for investors: HDV emphasizes defensive healthcare/energy exposure while FDVV’s technology tilt (notably NVDA, AAPL, MSFT) implies higher volatility in exchange for higher total-return potential.

Analysis

The real signal here is factor packaging, not income. FDVV is effectively a large-cap growth basket with a dividend wrapper, so in a continued AI-led, low-volatility tape it should outperform plain dividend peers because multiple expansion in NVDA/AAPL/MSFT will swamp the yield differential. HDV is the cleaner defensive carry trade: lower beta, lower drawdown, and more exposure to cash-flow stability if growth slows or the market starts rewarding balance-sheet quality over momentum.

Second-order, the ETF construction matters more than the holdings list. Incremental passive inflows into either product are too small to move the mega-caps meaningfully, so the tradable edge is the regime exposure: FDVV behaves like a diluted QQQ, while HDV behaves like a defensive value sleeve. If rates stay elevated or credit spreads widen, HDV should attract reallocations from income mandates; if rates fall and AI capex enthusiasm persists, FDVV’s tech tilt becomes the hidden lever.

The contrarian miss is that these funds are not substitutes at identical yields. The 33bp beta gap and the materially worse drawdown profile for FDVV imply investors are being paid very little extra to own a more cyclical factor mix. No urgent event catalyst is present, so this is more portfolio-construction than standalone alpha. The thesis is falsified if tech breadth remains strong, 10Y yields break meaningfully lower, or energy/pharma underperform enough to drag HDV’s defensive mix relative to growth.

Key Decisions for Investors

• Prefer HDV over FDVV for core dividend exposure on a 6-18 month horizon; the lower beta and better drawdown profile are the primary compensation for slightly lower growth participation.
• Tactically, consider long HDV / short FDVV as a relative-value pair for a risk-off or higher-for-longer rates backdrop; target 5-10% relative outperformance for HDV over 1-3 months, and cover if NVDA/MSFT/AAPL earnings reaccelerate or the Fed turns decisively dovish.
• Do not treat FDVV as a true dividend substitute for QQQ-equivalent tech exposure; if the goal is AI beta with income veneer, size it as a satellite position, not a core yield holding.
• Watch for a reversal trigger in 10Y Treasury yields and semiconductor guidance: a sharp yield decline or broad tech EPS revision upgrade would likely widen FDVV’s lead and invalidate the defensive pair trade.